Αποτελέσματα Αναζήτησης
16 Αυγ 2024 · This release contains forward-looking information about Pfizer’s investigational modified RNA (modRNA) influenza vaccine candidates, potential next-generation mRNA flu and combination vaccine formulations, Pfizer’s and BioNTech’s mRNA-based combination vaccine candidate for influenza and COVID-19, the flu and COVID/flu combination ...
- Coronavirus COVID-19: Vaccine, Drug and Treatment Updates - Pfizer
Pfizer Inc. and BioNTech SE today announced updated topline...
- Pfizer and BioNTech Provide Update on Booster Program in Light of the ...
The Pfizer-BioNTech COVID19 Vaccine is authorized for use...
- Coronavirus COVID-19: Vaccine, Drug and Treatment Updates - Pfizer
Pfizer Inc. and BioNTech SE today announced updated topline results from analysis of 927 confirmed symptomatic cases of COVID-19 observed in their pivotal Phase 3 study through March 13, 2021, showing the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, was 91.3% effective against COVID-19, measured seven days through up to six months after the ...
27 Ιουν 2024 · Recommendation is based on pre-clinical and epidemiological data showing that the JN.1-adapted monovalent COVID-19 vaccine generates an improved immune response against multiple JN.1 sublineages. Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission.
18 Αυγ 2022 · Updated 18 August 2022, to reflect the latest SAGE recommendations. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for the use of the Pfizer BioNTech (BNT162b2) vaccine against COVID-19.
The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech...
8 Ιουλ 2021 · The Pfizer-BioNTech COVID19 Vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
23 Αυγ 2021 · Full federal approval for the Pfizer-BioNTech coronavirus vaccine for those 16 and older is opening the way for institutions like the military, corporate employers, hospitals and school...
